Steven Lichtman

Stock Analyst at Oppenheimer

(1.05)
# 2228
Out of 5,438 analysts
77
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DXCM DexCom
Maintains: Outperform
95 102
77.88 30.97% 9 Jul 31, 2025
BSX Boston Scientific
Maintains: Perform
110 118
102.78 14.81% 3 Jul 24, 2025
PODD Insulet
Maintains: Outperform
312 324
304.75 6.32% 4 May 9, 2025
ZBH Zimmer Biomet Holdin...
Maintains: Outperform
145 135
100.02 34.97% 7 Oct 15, 2024
MNKD MannKind
Maintains: Outperform
10 12
3.42 250.88% 2 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
103 110
84.68 29.9% 3 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
92 94
92.75 1.35% 10 Aug 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
72 65
6.64 878.92% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 58
10.11 473.69% 1 Jun 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 11
12.06 -8.79% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12
8.44 42.18% 2 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 87
84.05 3.51% 1 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.72 386.11% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 9 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
273 288
376.68 -23.54% 1 Jul 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
105
86.99 20.7% 3 Jul 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
150
27.29 449.65% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
83 85
70.89 19.9% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Apr 12, 2017